Gut Comfort Probiotics - 30 Capsules

How do I use the iIntestinal Comfort Probiotics food supplement?

Take 1 capsule a day, swallowed with a glass of water.

1 jar = 1 month's use

The Intestinal Comfort Probiotics food supplement is a formula specially developed to help improve digestive and intestinal disorders:

• Contains the clinically proven patented ingredient SynbÆctive® Smilingut, made up of the probiotic strains Bifidobacterium lactis BL050, Lactobacillus rhamnosus LRH020, Lactobacillus plantarum PBS067

• Combined with Lactobacillus plantarum LP01 and Bifidobacterium breve BR03, which have also been the subject of clinical studies linked to improving intestinal transit.

• Supplemented with prebiotic fibre (Acacia fibre), beneficial for the intestinal microbiota.

Why take Intestinal Comfort Probiotics food supplement?

• to help ease bowel movements on a daily basis or after an episode of imbalance

• to help with sluggish bowel movements

• to promote intestinal health

• to support the balance of the microbiota

• when travelling abroad

• Unique combination of 5 clinically-studied probiotic strains to help balance the intestinal flora

• High dosage of 16 billion CFU* per capsule for optimum effectiveness

• Dosage validated by clinical studies for the strains used

• Gastro-resistant capsules, enabling probiotics to be released directly from the intestine

• High-quality strains, manufactured in Europe and strictly controlled with each batch

• No unnecessary or controversial additives

For this Intestinal Comfort Probiotics food supplement, we have combined 2 blends of patented probiotic strains with clinically proven efficacy: SynbÆctive® Smilingut

• Consisting of a blend of 3 probiotic strains, Bifidobacterium lactis BL050, Lactobacillus rhamnosus LRH020 and Lactobacillus plantarum PBS067, this top-of-the-range active ingredient has benefited from many years of research.

• It has been the subject of a randomised, double-blind, placebo-controlled clinical trial (the gold standard in clinical trials) on a total of 100 people suffering from irritable bowel syndrome.

• This study showed an improvement in symptoms such as abdominal cramps and pain, constipation, bloating and flatulence in over 80% of subjects as early as 30 days after the start of the study.

• These beneficial effects persisted even after the probiotics were stopped.

• The strains demonstrated inhibitory activity against intestinal flora pathogens such as E. coli, E. feacalis and S. aureus, strains that cause intestinal discomfort.

• The SynbÆctive® Smilingut strains act in synergy, with a beneficial activity demonstrated to be greater for the mixture than for each of the 3 strains alone.

Mixture of strains Lactobacillus plantarum LP01, Bifidobacterium breve BR03:

• This synergy has also been shown to have beneficial effects on intestinal disorders, with clinical studies both on subjects suffering from irritable bowel syndrome, and on subjects wishing to improve their intestinal transit.

Function

Food supplements

Country of origin

Food supplement made and packaged in France.

Acacia from Africa, Probiotics from Italy.

Capacity

30 capsules

Learn more

Storage

Store away from light, heat and moisture. Close the jar tightly after each use.

Precautions

• Not a substitute for a varied, balanced diet and a healthy lifestyle.

• Do not exceed the recommended daily dose.

• For adults only.

• Not recommended for use in pregnancy or while breastfeeding.

• Keep out of reach of children.

Mezzasalma et al. 2016.

A randomized, double-blind, placebo-controlled trial: the efficacy of multispecies probiotic supplementation in alleviating symptoms of irritable bowel syndrome associated with constipation. BioMed Research International.

Saggioro et al. 2004.

Probiotics in the treatment of Irritable Bowel Syndrome. Journal of Clinical Gastroenterology. 38(8) : 104-106.

Del Piano et al. 2005.

The use of probiotics in the treatment of constipation in the elderly. CIBUS. 1(1):23-30

Del Piano et al. 2010.

The use of probiotics in healthy volunteers with evacuation disorders and hard stools: a doubleblind, randomized, placebo-controlled study. Journal of Clinical Gastroenterology. 44 Suppl 1: 30-4.